Adlay, an ancient functional plant with nutritional quality, improves human health

Wen F. Weng, Yan Peng, Xin Pan, Jun Yan, Xiang D. Li, Zhi Y. Liao, Jian P. Cheng, An J. Gao, Xin Yao, Jing J. Ruan, Mei L. ZhouFrontiers in Nutrition 2022 · DOI

Adlay (Coix lacryma-jobi L.), a close relative of maize and sorghum, has been cultivated for over 8,000 years across Asia and Africa. Despite its long history and high value in traditional medicine, it is often relegated to the status of a "minor crop." Recent research, however, is shedding light on its extraordinary nutritional profile and therapeutic potential, positioning adlay as a key player in the future of functional foods and nutraceuticals.

The "Minor Crop" Challenge

Originating in the tropical and subtropical regions of Asia, particularly southwest China, adlay has long been prized for both its dietary and medicinal properties. However, the industry faces significant hurdles: low yields, a lack of standardized high-quality varieties, and the destruction of wild germplasm due to land development. By synthesizing decades of phytochemical and genomic data, researchers aim to transition adlay from a traditional remedy to a high-yield, scientifically-validated staple.

Adlay (Coix lacryma-jobi L.) plant growing in the field.

Phytochemical Profile: A Nutritional Powerhouse

Adlay stands out among cereals for its remarkable nutrient density. Its protein content can reach up to 31.72% in wild varieties, significantly exceeding that of rice, maize, and wheat. More importantly, it offers a balanced amino acid profile rich in essential components like lysine and tryptophan.

The lipid profile is equally impressive, with over 83% of its fat content composed of unsaturated fatty acids, primarily oleic and linoleic acids, which are vital for cardiovascular health. Beyond basic macronutrients, adlay is a rich source of vitamins, minerals, and unique bioactive secondary metabolites.

Polished adlay seeds, a staple in traditional medicine and modern functional diets.

Therapeutic Mechanisms: From Inflammation to Oncology

The medicinal reputation of adlay is rooted in specific bioactive compounds such as coixenolide and coixol. Coixenolide was the first anti-tumor component discovered in the plant; clinical studies have demonstrated an 86.7% effective treatment rate when used for advanced nasopharyngeal carcinoma. Coix Seed Oil (CSO) works by downregulating the PRMT5-PI3K/AKT signaling pathway, inducing apoptosis in cancer cells and restricting their nutrient supply.

Meanwhile, coixol acts as a potent anti-inflammatory agent. It suppresses the NF-κB and NLRP3 inflammasome pathways, providing a molecular basis for adlay’s traditional use in treating inflammatory conditions. Additionally, the plant exhibits significant antioxidant capacity, with specific seed fractions showing high total phenolic content and oxygen radical absorbance capacity (ORAC).

Genomic Frontiers: Engineering the Next Superfood

The path to industrializing adlay lies in modern genomics. Recent "de novo" assembly efforts have produced a high-quality draft genome (~1.619 Gb) with a 91.4% BUSCO score, providing a blueprint for molecular breeding. Comparative genomics have already revealed the genetic basis for key domestication traits, such as the "soft shell" variety, which resulted from the inhibition of cell division and wall biogenesis.

Future work will likely leverage CRISPR-Cas9 for site-directed mutagenesis and third-generation hybrid breeding. These tools will allow scientists to develop "elite" cultivars that combine high yields with optimized levels of health-promoting secondary metabolites.

Conclusion

Adlay represents a bridge between ancient agricultural wisdom and modern molecular science. While challenges remain in conservation and yield optimization, its unique combination of high protein, beneficial fats, and potent anti-tumor compounds makes it an invaluable resource. As genomic tools continue to mature, adlay is poised to move from the fringes of agriculture to the center of the global functional food market.

Summary updated

Abstract

Adlay (<i>Coix lacryma-jobi</i> L.), a crop closed related to maize (<i>Zea mays</i> L.) and sorghum (<i>Sorghum bicolor</i> L.), originated in tropical/subtropical regions of Asia and Africa; southwest China primary center of this plant's origin, evolution and migration. Adlay is a traditional high-value minor crop used for both medicinal and dietary purposes. Adlay has anti-tumor, anti-bacterial, anti-inflammatory, analgesic, blood sugar-lowering, and blood lipid-lowering effects. To clarify the main bioactive components and phytochemical compounds and to fully explore their utility, this review summarizes the research done on the main functional ingredients of adlay, including amino acids and proteins, oils, vitamins and minerals, polysaccharides, and polyphenols. This study also highlighted the application of genome sequencing to tailor nutrient-rich adlay cultivars and nutraceutical product development. Additionally, the acquisition of high-density genomic data combined with next-generation phenotypic analysis will undoubtedly improve our understanding of the potential genetic regulation of adlay nutraceutical traits. This review provides new insights and ideas for the research of adlay in comparison and evolutionary genomics, and a useful reference for molecular breeding and genetic improvement of this important minor crop.
BibTeX
@inproceedings{weng2022adlay,
  author = {Wen F. Weng and Yan Peng and Xin Pan and Jun Yan and Xiang D. Li and Zhi Y. Liao and Jian P. Cheng and An J. Gao and Xin Yao and Jing J. Ruan and Mei L. Zhou},
  title = {{Adlay, an ancient functional plant with nutritional quality, improves human health}},
  booktitle = {Frontiers in Nutrition},
  year = {2022},
  doi = {10.3389/fnut.2022.1019375},
}
Figure